ABUS vs TSM Stock Comparison

ABUS currently leads TSM in this stock comparison, with AIQ scores of 70 vs 67. The clearest difference is value, while TSM has the stronger momentum profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 3 points
ABUS
Healthcare
vs
TSM
Technology
ABUS
Arbutus Biopharma Corp
Leads
Price
$4.09
Day move
+1.49%
AIQ Score
70/100
Best edge
Value
Sector
Healthcare
TSM
Taiwan Semiconductor Manufacturing Company Limited
Price
$399
Day move
-1.67%
AIQ Score
67/100
Best edge
Momentum
Sector
Technology

What is the main difference between ABUS and TSM?

ABUS leads the current stock comparison as Arbutus Biopharma Corp, with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Arbutus Biopharma Corp vs Taiwan Semiconductor Manufacturing Company Limited

Data as of Nov 15, 2026· market close· Cross-sector · Healthcare vs Technology· Coverage 62/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 3/10

ABUS leads

ABUS leads by 3 AIQ points, primarily on Value and Quality, having only recently taken the lead back from TSM.

Fragile: 3 of 5 evidence groups support ABUS, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 3 of 5Comparison trend: Reversed
ABUS

Arbutus Biopharma Corp

Leads
AIQ Score
70/100
AIQ Edge Score
9/10
TSM

Taiwan Semiconductor Manufacturing Company Limited

AIQ Score
67/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors ABUS over TSM, 70 versus 67 as of Nov 15, 2026. ABUS's advantage is driven primarily by stronger value and quality, while TSM holds the stronger momentum profile. ABUS also shows the weaker technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor ABUS today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 3 points. ABUS lead: Reversed — TSM led by 4 AIQ points 30 sessions ago; ABUS now leads by 3.

Compare Arbutus Biopharma Corp and Taiwan Semiconductor Manufacturing Company Limited across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

ABUS
+24.3%
TSM
+257.5%

Total return comparison

Growth of $10,000, distributions reinvested

ABUS $12,432 · TSM $35,753

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare ABUS and TSM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ABUS advantage
0
TSM advantage
  • Value92 vs 66
    ABUS +26
  • Momentum51 vs 66
    TSM +15
  • Quality82 vs 74
    ABUS +8
  • Risk Resilience62 vs 58
    ABUS +4

3 of 5 evidence groups favor ABUS. ABUS’s edge is concentrated in value and quality; TSM keeps a meaningful momentum edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ABUS0 AIQ

No factor moved materially.

New signals

  • Death Cross Active — bearish, trend, long horizon (0.45%)
  • Downtrend Structure Active — bearish, trend, long horizon
TSM0 AIQ

Largest factor move: Momentum +2, not enough on its own to move the overall score.

New signals

  • Price Lost 200-Day MA — bearish, trend, long horizon

ABUS's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — ABUS and TSM both carry a full feed there.

The central trade-off

ABUS (Arbutus Biopharma Corp): the stronger current systematic profile, led by value and quality.

TSM (Taiwan Semiconductor Manufacturing Company Limited): the counter-case, on momentum, technicals — but at materially higher volatility, 61.7% against 52.1%.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

ABUS

ABUS on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

TSM

TSM on combined revenue and EPS growth.

Value

ABUS

ABUS on the peer-relative Value factor, by 26 points.

Momentum

TSM

TSM on the Momentum factor, by 15 points.

Lower downside

ABUS

ABUS on Risk Resilience, by 4 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureABUSTSMNote
Implied upside to target—+44.5%Level
Target dispersion—+26.9%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering122Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 5 covered evidence groups favor ABUS. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven70 vs 67
FundamentalsABUSon balancerevenue growth -70.5% vs 17.6%; EPS growth 11% vs 8%; TTM ROE 68.9% vs 10.9%; gross margin 100% vs 65.8%; operating margin 79.9% vs 57.9% — ABUS takes 4 of 5 decided legs, not all of them
ValuationABUSValue 92 vs 66
TechnicalsTSMPrice vs 50-day -8.3% vs -7.3%; vs 200-day -8.7% vs -1.1%
Risk ResilienceABUSRisk Resilience 62 vs 58
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ABUS and TSM and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 3 points. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ABUS.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

ABUS lead: Reversed — TSM led by 4 AIQ points 30 sessions ago; ABUS now leads by 3.

May 27ABUS leads above the line · TSM leads belowNov 13
Today
ABUS +3
70 vs 67
7 sessions ago
Level
68 vs 68
30 sessions ago
TSM +4
68 vs 72
90 sessions ago
ABUS +4
72 vs 68

The lead changed hands 4 times in this window, most recently on Nov 11 when ABUS moved ahead of TSM.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ABUSConflicted

2 bullish / 3 bearish / 1 neutral, conflicted

Only ABUS

  • Death Cross Active — bearish, trend, long horizon (0.45%)
  • Distribution Pattern — bearish, volume, medium horizon (1.36x)
  • Downtrend Structure Active — bearish, trend, long horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-3.1%)
TSMConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only TSM

  • Golden Cross Active — bullish, trend, long horizon (6.71%)
  • Price Lost 200-Day MA — bearish, trend, long horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon

Both carry 2 more signals that do not separate them: ATR Expansion - Breakout Mode, MACD Histogram Expanding Bullish.

ABUS leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ABUSNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.49%, AIQ 0 points).

TSMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.67%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1TSM closes the Value gap — currently 26 points behind, the largest single contributor to ABUS's edge.
  2. 2TSM's Price Lost 200-Day MA resolves — a bearish trend rule currently active against it.
  3. 3ABUS's conflicting signal state resolves bearish — it currently carries 2 bullish and 3 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

ABUS leads on balance
MetricABUSTSM
Revenue growth (YoY)-70.5%17.6%
EPS growth (YoY)11%8%
Gross margin100%65.8%
Operating margin79.9%57.9%
Return on equity (TTM)68.9%10.9%
Debt to equity00.14

Performance

TSM leads 4 of 6 windows
MetricABUSTSM
1 week (5 sessions)11.9%6.2%
1 month (20 sessions)-3.1%-3.4%
3 months (63 sessions)-13.2%-7.5%
6 months (126 sessions)-3.5%-1.4%
Year to date-15%31.2%
1 year (252 sessions)-15.5%37.2%

Technicals

TSM has the stronger structure
MetricABUSTSM
RSI (14)48.545.3
ADX (14)29.229.2
Price vs 50-day-8.3%-7.3%
Price vs 200-day-8.7%-1.1%
Volatility (1M, annualized)52.1%61.7%

Risk

ABUS is the more resilient
MetricABUSTSM
Beta1.192.16
Sharpe ratio-0.090.95
Sortino ratio-0.131.37
Max drawdown-30%-27.3%
Current drawdown-21.6%-17.9%
Annualized volatility45.9%41.8%
Value at risk (95%)-4.4%-4.2%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ABUS or TSM?

On the Algovestiq AIQ Score, ABUS is the stronger of the two as of Nov 15, 2026, scoring 70 against TSM's 67. The edge comes from value and quality. TSM is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ABUS or TSM the better buy right now?

ABUS carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 3 points. Treat the lead as provisional.

Why does the AIQ Score favor ABUS over TSM?

The composite weights Quality, Value, Momentum and Risk Resilience. ABUS leads Value by 26 points; TSM leads Momentum by 15 points; ABUS leads Quality by 8 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, ABUS or TSM?

Analyst price targets imply not covered upside for ABUS and +44.5% for TSM. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ABUS or TSM?

ABUS is the better-valued of the two on the peer-relative Value factor. ABUS on the peer-relative Value factor, by 26 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ABUS or TSM?

TSM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ABUS or TSM?

TSM on the Momentum factor, by 15 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ABUS or TSM?

ABUS is the more resilient of the two, so the other name carries the higher downside risk. ABUS on Risk Resilience, by 4 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ABUS more profitable than TSM?

ABUS leads on the comparable margin measures — gross margin 100% vs 65.8%; operating margin 79.9% vs 57.9%; ttm roe 68.9% vs 10.9%.

Is ABUS's lead over TSM getting stronger or weaker?

ABUS lead: Reversed — TSM led by 4 AIQ points 30 sessions ago; ABUS now leads by 3. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 4 times in that window, most recently on 2026-11-11, when ABUS moved ahead of TSM.

What would change the ABUS vs TSM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: TSM closes the Value gap — currently 26 points behind, the largest single contributor to ABUS's edge; TSM's Price Lost 200-Day MA resolves — a bearish trend rule currently active against it; ABUS's conflicting signal state resolves bearish — it currently carries 2 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about ABUS and TSM?

ABUS: 2 bullish / 3 bearish / 1 neutral, conflicted. TSM: 2 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ABUS is Death Cross Active (bearish, long horizon). On TSM it is Golden Cross Active (bullish, long horizon).

Compare ABUS and TSM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.